CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that management will participate in the following upcoming investor conferences to discuss the Company and its programs, including reni-cel: Morgan Stanley 22 nd Annual Global Healthcare Conference Format: Fireside Chat Date: Wednesday, September 4 Time: 4:05 p.m. ET Location: New... Read More